Literature DB >> 603022

Galanthamine hydrobromide, a longer acting anticholinesterase drug, in the treatment of the central effects of scopolamine (Hyoscine).

D A Cozanitis.   

Abstract

Galanthamine hydrobromide, an anticholinesterase drug capable of penetrating the blood-brain barrier, was used in a patient demonstrating central effects of scopolamine (hyoscine) overdosage. It is longer acting than physostigmine and is used in anaesthesia to reverse the non-depolarizing neuromuscular block. However, studies into the dose necessary to combating scopolamine intoxication are indicated.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 603022

Source DB:  PubMed          Journal:  Anaesthesist        ISSN: 0003-2417            Impact factor:   1.041


  3 in total

1.  The snowdrop, wellspring of galanthamine : A brief descriptive and scientific history.

Authors:  Dimitri A Cozanitis
Journal:  Wien Med Wochenschr       Date:  2021-01-27

2.  Antagonistic activity of galanthamine on constant infusion of pancuronium in rats.

Authors:  D A Cozanitis; F van de Pol; H van Wezel; J F Crul
Journal:  Experientia       Date:  1981-12-15

Review 3.  Pharmacological management of anticholinergic delirium - theory, evidence and practice.

Authors:  Andrew H Dawson; Nicholas A Buckley
Journal:  Br J Clin Pharmacol       Date:  2015-12-29       Impact factor: 4.335

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.